Exchange: NASDAQ·Updated 07:30 PM EST
SCNX logo

SCNX Scienture Holdings Inc.

$2.19
$0.1571
(6.45%)
Today
Closed $2.28
$0.0879
(3.86%)
After Hours
Mkt Cap$4.07M
Vol29,859.00

About SCNX

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Commack, NY.
43

Bearish Sentiment

How do you feel about SCNX?

Stock_Catcher
$SCNX SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™
6
JackCampbell
$SCNX If SCNX can keep OpEx flat or declining while revenues scale at this pace, the operating leverage will drive them into profitability much faster than expected. With 90%+ gross margins, capped expenses mean almost every new dollar drops straight to the bottom line.
6
BEATWALLSTREET
$SCNX Wouldn't surprise me to see this drop below $2 between today and tomorrow. Maxim is shorting while insiders are quietly dumping shares. But remember, the more you buy, the more shares they print, and the lower the price goes. It's simple math. Stop feeding the dilution machine. Without retail constantly buying their shares, these clowns wouldn't last another month.
1
1
BEATWALLSTREET
$SCNX They're burning through cash at an alarming rate. At their current pace, they have enough runway to make it until around year-end, give or take a month. On top of that, starting January 2027, they're on the hook for $175K per month in payments to Streeterville on the $11 million debt they already burned through. The cash crunch is getting serious, and with those obligations piling up, I'd expect another offering sooner rather than later. Wouldn't be surprised if dilution is right around the corner.
1
1
JackCampbell
$SCNX successfully trimmed internal overhead, reducing general administrative costs and wages, while strategically reallocating capital toward commercialization and pipeline development. Despite flat overall spending, professional fees and R&D investments scaled up effectively to fuel product growth without bloating the corporate structure.
4
pudge83
$SCNX i would say this is a discount but probably will be the high of the next 6 months lol
3
Ningjie
$SCNX In fact, the company’s fundamentals remain sound. On the contrary, record-breaking revenue of $1.25 million, combined with a high gross margin of 81.3%, clearly validates the commercial value inherent in the company’s core asset, REZENOPY™. Looking ahead, the market will be closely monitoring the repeat purchase rate following the initial product rollout to see if it can drive a significant surge in revenue by the fourth quarter of 2027 (and the first quarter of the following year). Should this growth materialize, the company would be well-positioned to reduce its heavy reliance on "at-the-market" (ATM) equity offerings and debt restructuring with investors.
3
JackCampbell
$SCNX BIG Market Opportunity: EPANED from Azurity Pharma (~$43M peak) validated the demand for liquid antihypertensives, but Arbli™ (Losartan) targets a 24x larger patient base with a modern, FDA-approved ARB formulation. Operational Advantages: Arbli™ eliminates cold-chain logistics with 24-month room-temperature stability, features a taste-masked peppermint flavor for better compliance, and replaces error-prone compounding in hospitals. Long-Term Exclusivity: Backed by robust US patents securing exclusivity through October 2041, Arbli™ provides a fully protected, long-term runway for high-margin growth.
2
Diverstj981
$SCNX the lack of communication and transparency from these Indian pieces of shxt regarding their earnings announcements is infuriating.
2
Diverstj981
$SCNX Zack's has earnings scheduled for November 11th. TradingView November 12th. Anyone know which it is? Why are these clowns SO opposed to actual transparency and communication?
2
BEATWALLSTREET
$SCNX I told you...the Indians are quite... nothing but dilution knowing this is their last chance hope the market crashes another 50% and stays down for a while, just long enough to bankrupt all these scam companies and wipe them out for good. All they do is rob American retails blind, and the market would be better off without them.
1
Ningjie
$SCNX The third-quarter financial report explicitly discloses that the initial customer orders for REZENOPY have been delivered and shipped via direct sales channels. For SCNX, the value of direct sales channels lies not only in their potential to boost REZENOPY’s sales revenue but also in their capacity to improve the company’s cash conversion cycle.
1
Diverstj981
$SCNX quite the AH fade here. Took most of today back. Keeping an eye on pre-market more than anything tho.
1
StockTwit87
$SCNX maxim Group maintained a buy rating for this stock but drastically reduced the price target from $37.50 to $6!!

Advertisement|Remove ads.